Robert Joseph Smith - Sep 19, 2025 Form 4 Insider Report for CITIUS ONCOLOGY, INC. (CTOR)

Role: Director
Signature: /s/ Alexander M. Donaldson, by Power of Attorney
Stock symbol: CTOR
Transactions as of: Sep 19, 2025
Transactions value $: $0
Form type: 4
Date filed: 9/23/2025, 04:10 PM
Previous filing: Dec 16, 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Smith Robert Joseph	Director	C/O CITIUS ONCOLOGY, INC., 11 COMMERCE DRIVE, 1ST FLOOR, CRANFORD	/s/ Alexander M. Donaldson, by Power of Attorney	2025-09-23	0002008764

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CTOR	Common Stock	Award	$0	+300K		$0.00	300K	Sep 19, 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CTOR	Stock Option (Right to Buy)						125K	Sep 19, 2025	Common Stock	125K	$1.07	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock awards granted on September 19, 2025. The shares will vest in three substantially equal installments on the first, second and third anniversaries of the grant date, subject to the Reporting Person's Continuous Service to Citius Oncology, Inc. (the "Company") or a Related Entity (as defined in the award agreement) as of the applicable vesting date.
F2	These options were granted on December 12, 2024. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the grant date, subject to the Reporting Person's Continuous Service to the Company or a Related Entity (as defined in the award agreement) as of the applicable vesting date.